line

Current 25 - Four Drugs Found Beneficial for Glycemic Reduction in Patients with Type 2 Diabetes

16 February 2023
Cardi-OH
Read more
line

Current 24 - Support for SGLT2i Use in Heart Failure with Preserved Ejection Fraction

17 January 2023
Cardi-OH
Read more
line

Current 23 - Update on the Diagnosis and Management of Nonalcoholic Fatty Liver Disease

15 November 2022
Cardi-OH
Read more
line

Current 22 - Update on E-Cigarettes and Cardiovascular Disease Risk

20 October 2022
Cardi-OH
Read more
line

Current 21 - Updated USPSTF Recommendations Focus on Individualized Initiation of Aspirin for Primary Prevention of Cardiovascular Disease

01 September 2022
Cardi-OH
Read more
line

Current 20 - American Heart Association’s Scientific Statement Focuses on Cardiovascular Risk Reduction in Adults With Type 2 Diabetes

29 June 2022
Cardi-OH
Read more
line

Current 19 - U.S. Adults Experienced Significant Increase in Blood Pressure During COVID-19 Pandemic

27 May 2022
Cardi-OH
Read more
line

Current 18 - Underrecognized Impact of Pollution on Cardiovascular Disease: NEJM Review

22 April 2022
Cardi-OH
Read more
line

Current 17 - Latest ADA Standards of Care Provide Updated Screening Thresholds and Opportunities for Personalized Therapeutics

30 March 2022
Cardi-OH
Read more
line

Current 16 - Report Highlights Negative Impact of COVID-19 Pandemic on U.S. Obesity Rates

03 March 2022
Cardi-OH
Read more
Subscribe to Currents

 

© 2020 Cardi-OH